EXCESSIVE DAYTIME SLEEPINESS
Clinical trials for EXCESSIVE DAYTIME SLEEPINESS explained in plain language.
Never miss a new study
Get alerted when new EXCESSIVE DAYTIME SLEEPINESS trials appear
Sign up with your email to follow new studies for EXCESSIVE DAYTIME SLEEPINESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pitolisant shows promise for Long-Term control of idiopathic hypersomnia
Disease control CompletedThis study looks at the long-term safety and effectiveness of pitolisant in adults with idiopathic hypersomnia, a condition causing excessive daytime sleepiness. Participants had already completed a previous study. The goal is to see if pitolisant remains safe and helps control s…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill aims to stop Narcolepsy's sudden muscle weakness
Symptom relief CompletedThis study tested an experimental drug called AXS-12 (reboxetine) in 90 people with narcolepsy who experience cataplexy (sudden muscle weakness) and excessive daytime sleepiness. Participants took either the drug or a placebo twice daily for several weeks. The main goal was to se…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Sleep apnea drug shows promise for brain fog
Symptom relief CompletedThis study tested a drug called solriamfetol in 59 adults with obstructive sleep apnea who also had trouble thinking clearly and felt very sleepy during the day. The goal was to see if the drug could improve cognitive function, like attention and processing speed. Participants to…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE4 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
New drug shows promise for reducing narcolepsy attacks over the long term
Symptom relief CompletedThis study looked at the long-term safety and effectiveness of a drug called AXS-12 for people with narcolepsy who also have sudden muscle weakness (cataplexy) and severe daytime sleepiness. 68 people who had already completed an earlier study took AXS-12 and were monitored for s…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC